
Scientific Health Development is a venture capital firm that primarily invests in early-stage (Series A and B) US-based MedTech companies. Their strategy focuses on innovative medical technologies that address unmet clinical needs, improve patient outcomes, and reduce economic burden, often seeking those with near-term value inflection points.
75% of their portfolio is in Enterprise Software. Their most common stage is series-a (75% of deals). Average disclosed round size is $9.2M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$51.2M
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $7M | Oct 2025 | |
| Series A | $7M | Apr 2025 | |
| Series B | $10M | Jun 2021 | |
| Series A | $12.6M | May 2021 |
Top Co-Investors
Last updated: 28 April 2026